REBECCA USSERY: Open Payments
NPI 1063181956 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 42 payments from 15 companies in 2025. Trend: 2023 $1,002 · 2024 $564 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $153 |
| Novo Nordisk Inc | 7 | $139 |
| AstraZeneca Pharmaceuticals LP | 7 | $120 |
| Astellas Pharma US Inc | 3 | $71 |
| Lilly USA, LLC | 4 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: PREVNAR 20, Ozempic, Veozah, ELIQUIS, Wegovy, BREZTRI, AIRSUPRA, GEMTESA.
Industry payments across GA — which companies pay providers there.
